Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia.
Buresh
A
A
Perentesis
J
J
Rimsza
L
L
Kurtin
S
S
Heaton
R
R
Sugrue
M
M
List
A
A
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000970:Antineoplastic Agents / Q000009:adverse effects*; D051231:Farnesyltranstransferase; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D007964:Leukocytosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D013902:Radiography, Thoracic; D003986:Dibenzocycloheptenes
D019883:Alkyl and Aryl Transferases; D000970:Antineoplastic Agents; D051231:Farnesyltranstransferase; D010880:Piperidines; D011725:Pyridines; C115354:lonafarnib; D003986:Dibenzocycloheptenes